TRNP1
TMF-regulated nuclear protein 1
Also known as: C1orf225, TRNP, TRNP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6NT89
- Gene
- TRNP1
- Ensembl
- ENSG00000253368
- Chromosome
- 1
- Canonical length
- 227 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable DNA binding activity. Predicted to be involved in several processes, including cerebellar cortex morphogenesis; neural precursor cell proliferation; and regulation of cell population proliferation. Predicted to be located in euchromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
227 residues, UniProt reviewed canonical sequence.
>Q6NT89|TRNP1
1 MPGCRISACG PGAQEGTAEQ RSPPPPWDPM PSSQPPPPTP TLTPTPTPGQ SPPLPDAAGA
61 SAGAAEDQEL QRWRQGASGI AGLAGPGGGS GAAAGAGGRA LELAEARRRL LEVEGRRRLV
121 SELESRVLQL HRVFLAAELR LAHRAESLSR LSGGVAQAEL YLAAHGSRLK KGPRRGRRGR
181 PPALLASALG LGGCVPWGAG RLRRGHGPEP DSPFRRSPPR GPASPQRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRNP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 118 nTPM
Expression across tissuesHPA
Tissue
- stomach: 118 nTPM
- esophagus: 81 nTPM
- retina: 78 nTPM
- cerebral cortex: 37 nTPM
- heart muscle: 29 nTPM
- cerebellum: 29 nTPM
Single-cell type
- retinal bipolar cells: 374 nCPM
- esophageal apical cells: 293 nCPM
- foveolar cells: 112 nCPM
- pancreatic duct cells: 98 nCPM
- alveolar cells type 1: 79 nCPM
- breast myoepithelial cells: 78 nCPM
Immune cell
- intermediate monocyte: 0.6 nTPM
- non-classical monocyte: 0.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 89 nTPM
- pons: 65 nTPM
- thalamus: 63 nTPM
- hypothalamus: 50 nTPM
- medulla oblongata: 48 nTPM
- cerebellum: 42 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0.38
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cerebellar cortex morphogenesis
- neural precursor cell proliferation
- regulation of cell cycle
- regulation of cell population proliferation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TMF-regulated nuclear protein 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRNP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRNP1 as an antibody target. Whether an autoantibody or antibody against TRNP1 could matter depends on whether native TRNP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRNP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRNP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...